Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Vitamin D status and response to daily 400 IU vitamin D3 and weekly alendronate 70 mg in men and women with osteoporosis.

Karaplis AC, Chouha F, Djandji M, Sampalis JS, Hanley DA.

Ann Pharmacother. 2011 May;45(5):561-8. doi: 10.1345/aph.1P439. Epub 2011 Apr 26.

PMID:
21521859
2.

Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial.

Recker R, Lips P, Felsenberg D, Lippuner K, Benhamou L, Hawkins F, Delmas PD, Rosen C, Emkey R, Salzmann G, He W, Santora AC.

Curr Med Res Opin. 2006 Sep;22(9):1745-55.

PMID:
16968578
3.

Minimum required vitamin D level for optimal increase in bone mineral density with alendronate treatment in osteoporotic women.

Ishijima M, Sakamoto Y, Yamanaka M, Tokita A, Kitahara K, Kaneko H, Kurosawa H.

Calcif Tissue Int. 2009 Nov;85(5):398-404. doi: 10.1007/s00223-009-9295-x. Epub 2009 Oct 1.

PMID:
19795092
4.

Vitamin D status and response to treatment in post-menopausal osteoporosis.

Adami S, Giannini S, Bianchi G, Sinigaglia L, Di Munno O, Fiore CE, Minisola S, Rossini M.

Osteoporos Int. 2009 Feb;20(2):239-44. doi: 10.1007/s00198-008-0650-y. Epub 2008 Jun 13.

PMID:
18551242
5.

Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trial.

Binkley N, Ringe JD, Reed JI, Ljunggren O, Holick MF, Minne HW, Liu M, Lamotta A, West JA, Santora AC.

Bone. 2009 Apr;44(4):639-47. doi: 10.1016/j.bone.2008.05.002. Epub 2008 May 15.

PMID:
19185560
6.

Vitamin D insufficiency does not affect response of bone mineral density to alendronate.

Antoniucci DM, Vittinghoff E, Palermo L, Black DM, Sellmeyer DE.

Osteoporos Int. 2009 Jul;20(7):1259-66. doi: 10.1007/s00198-008-0799-4. Epub 2008 Nov 29.

PMID:
19043656
7.

Cost-effectiveness of a fixed dose combination of alendronate and cholecalciferol in the treatment and prevention of osteoporosis in the United Kingdom and The Netherlands.

Jansen JP, Gaugris S, Bergman G, Sen SS.

Curr Med Res Opin. 2008 Mar;24(3):671-84. doi: 10.1185/030079908X260998. Epub 2008 Jan 24.

PMID:
18221588
8.

The patient's page. Bone health facts.

McKinney J.

South Med J. 2005 Oct;98(10):1058. No abstract available.

PMID:
16295830
9.

Randomized trial of alendronate plus vitamin D3 versus standard care in osteoporotic postmenopausal women with vitamin D insufficiency.

Ralston SH, Binkley N, Boonen S, Kiel DP, Reginster JY, Roux C, Chen L, Rosenberg E, Santora A; FOCUS-D (FOSAVANCE vs. Standard Care-Use and Study of Vitamin D) Trial.

Calcif Tissue Int. 2011 Jun;88(6):485-94. doi: 10.1007/s00223-011-9482-4. Epub 2011 Apr 11.

PMID:
21479913
10.

Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65-71 years: a 3-year randomized population-based trial (OSTPRE-FPS).

Kärkkäinen M, Tuppurainen M, Salovaara K, Sandini L, Rikkonen T, Sirola J, Honkanen R, Jurvelin J, Alhava E, Kröger H.

Osteoporos Int. 2010 Dec;21(12):2047-55. doi: 10.1007/s00198-009-1167-8. Epub 2010 Mar 4.

PMID:
20204604
12.

[Alendronate and vitamin D (Fosavance): persistence, adherence and importance of vitamin D].

Grazio S, Morović-Vergles J.

Reumatizam. 2007;54(2):89-92. Review. Croatian.

PMID:
18351154
13.

[FOSAVANCE -- alendronate plus vitamin D in a weekly tablet].

[No authors listed]

Praxis (Bern 1994). 2006 Jul 5;95(27-28):2 p following 1084. German. No abstract available.

PMID:
16888927
14.

Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.

McComsey GA, Kendall MA, Tebas P, Swindells S, Hogg E, Alston-Smith B, Suckow C, Gopalakrishnan G, Benson C, Wohl DA.

AIDS. 2007 Nov 30;21(18):2473-82.

PMID:
18025884
15.

[Current osteoporosis treatment: reasons for adding vitamin D to alendronate].

Anić B, Grazio S.

Reumatizam. 2006;53(2):63-5. Review. Croatian.

PMID:
17580557
16.
17.

Prescriptions for vitamin D among patients taking antiresorptive agents in Canada.

Hanley DA, Zhang Q, Meilleur MC, Mavros P, Sen SS.

Curr Med Res Opin. 2007 Jun;23(6):1473-80. Epub 2007 May 18.

PMID:
17559742
18.

[Very old patients with osteoporosis should be treated with alendronate].

Shiraki M.

Nihon Ronen Igakkai Zasshi. 2006 Jul;43(4):455-8. Japanese.

PMID:
16937932
19.

Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.

Bonnick S, Broy S, Kaiser F, Teutsch C, Rosenberg E, DeLucca P, Melton M.

Curr Med Res Opin. 2007 Jun;23(6):1341-9.

PMID:
17594775
20.

Changes in vitamin D metabolites during teriparatide treatment.

Cosman F, Dawson-Hughes B, Wan X, Krege JH.

Bone. 2012 Jun;50(6):1368-71. doi: 10.1016/j.bone.2012.02.635. Epub 2012 Mar 9.

PMID:
22426307
Items per page

Supplemental Content

Write to the Help Desk